The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

AIM WINNERS & LOSERS: dotDigital plunges after profit warning

Thu, 03rd Mar 2022 11:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Synairgen PLC, up 43% at 26.50 pence, 12-month range 10.00p-223.80p. The drug discovery and biotechnology company says studies conducted in the Netherlands have shown SNG001 has potent antiviral activity against SARS-CoV-2 Delta and Omicron variants at concentrations that are readily achievable. SNG001 is a formulation for inhalation containing the broad-spectrum antiviral protein interferon beta.

----------

AIM - LOSERS

----------

dotDigital Group PLC, down 48% at 77.40p, 12-month range 75.78p-295.00p. The online marketing warns on slowing growth. For six months ended December 31, pretax profit rises to GBP8.6 million from GBP7.1 million year before on revenue of GBP30.9 million, up from GBP28.2 million. Is not proposing interim dividend, to conduct full dividend review at year-end. Looking ahead, dotDigital notes "unwinding" of customer buying behaviour in post-lockdown environment, as reduced growth in demand for SMS marketing will hit growth. As such, now expects full year revenue growth to be slower than previous expectations during the current and future financial years.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Related Shares

More News
11 Oct 2023 11:19

IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Appoints ...

11 Oct 2023 10:26

Synairgen names Joseph Colliver as CFO

(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.

3 Oct 2023 09:59

Synairgen promotes Marcin Mankowski to chief medical officer

(Alliance News) - Synairgen PLC on Tuesday promoted Marcin Mankowski to chief medical officer, effective immediately.

21 Sep 2023 13:48

IN BRIEF: Synairgen narrows interim loss on reduced R&D spending

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Pretax lo...

22 Jun 2023 15:44

UK shareholder meetings calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.